Company page
Tg Therapeutics, Inc.
Tg Therapeutics, Inc. (TGTX) is a public company operating in the American market, with a market capitalization of approximately $8.15 billion. The company focuses on developing innovative therapies for patients with cancer and autoimmune diseases. Tg Therapeutics aims to address unmet medical needs through its research and development efforts.
- Ticker
- TGTX:NASDAQ
- Asset type
- Stock
- Market cap
- $8.15B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD